IL7 and acute lymphoblastic leukemia: To investigate the capacity of IL‐7 signalling and XBP1 to counteract the RAS signalling pathway, we examined whether removal of IL‐7 functionally impairs RAS signalling via IL‐7 receptor signalling in pre‐B ALL cells.